View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
OPM | RIN: 3206-AO27 | Publication ID: Spring 2022 |
Title: Prescription Drug and Health Care Spending | |
Abstract:
This rule implements the prescription drug reporting requirements that apply to group health plans, and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act. |
|
Agency: Office of Personnel Management(OPM) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 5 CFR 890 | |
Legal Authority: Pub. L. 116-260, Division BB, title I and title II |
Legal Deadline:
None |
||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: Local, State |
Small Entities Affected: No | Federalism: Yes |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 0938-AU66 | Related Agencies: Joint: HHS; |
Agency Contact: Padma Babubhai Shah Healthcare and Insurance Office of Personnel Management 1900 E Street NW, Washington, DC 20415 Phone:202 606-4056 Email: padma.shah@opm.gov |